In that study, we also used flow cytometry to confirm that the FOXP3+ cells were also CD3+CD4+CD25+CD127−, thus strengthening the suggestion that FOXP3 can serve as a useful marker for Treg in pancreatic cancer. This evidence concerns the gene CD4 and pancreatic neoplasm.